BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30014155)

  • 1. Phosphate wasting disorders in adults.
    Marcucci G; Masi L; Ferrarì S; Haffner D; Javaid MK; Kamenický P; Reginster JY; Rizzoli R; Brandi ML
    Osteoporos Int; 2018 Nov; 29(11):2369-2387. PubMed ID: 30014155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatonins: From Discovery to Therapeutics.
    Kritmetapak K; Kumar R
    Endocr Pract; 2023 Jan; 29(1):69-79. PubMed ID: 36210014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
    J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophosphatemia: an update on its etiology and treatment.
    Gaasbeek A; Meinders AE
    Am J Med; 2005 Oct; 118(10):1094-101. PubMed ID: 16194637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators.
    Shaikh A; Berndt T; Kumar R
    Pediatr Nephrol; 2008 Aug; 23(8):1203-10. PubMed ID: 18288501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor-induced hypophosphatemic osteomalacia].
    Ito N; Fukukmoto S
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathophysiology of hypophosphatemia.
    Ito N; Hidaka N; Kato H
    Best Pract Res Clin Endocrinol Metab; 2024 Mar; 38(2):101851. PubMed ID: 38087658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to the hypophosphatemic patient.
    Imel EA; Econs MJ
    J Clin Endocrinol Metab; 2012 Mar; 97(3):696-706. PubMed ID: 22392950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia.
    Kumar R
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):547-53. PubMed ID: 12187320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.
    Gattineni J; Baum M
    Pediatr Nephrol; 2010 Apr; 25(4):591-601. PubMed ID: 19669798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What have we learnt about the regulation of phosphate metabolism?
    Blumsohn A
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):397-401. PubMed ID: 15199289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibroblast growth factor-23 (FGF-23). Part I. Significance in phosphate homeostasis and bone metabolism].
    Fedak D; Bigaj K; Sułowicz W
    Przegl Lek; 2011; 68(4):231-8. PubMed ID: 21853680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of hypophosphatemia].
    Takeuchi Y
    Clin Calcium; 2016 Feb; 26(2):199-205. PubMed ID: 26813499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophosphatemia: A Practical Guide to Evaluation and Management.
    Tebben PJ
    Endocr Pract; 2022 Oct; 28(10):1091-1099. PubMed ID: 35940468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
    Fukumoto S
    Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 (FGF23) and the kidney.
    Tsagalis G; Psimenou E; Manios E; Laggouranis A
    Int J Artif Organs; 2009 Apr; 32(4):232-9. PubMed ID: 19569031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
    Sitara D; Razzaque MS; Hesse M; Yoganathan S; Taguchi T; Erben RG; Jüppner H; Lanske B
    Matrix Biol; 2004 Nov; 23(7):421-32. PubMed ID: 15579309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Phosphatonins" and the regulation of phosphorus homeostasis.
    Berndt TJ; Schiavi S; Kumar R
    Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1170-82. PubMed ID: 16275744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.